Article

Interview with Gert Bos, Executive Director & Partner.

Amanda Maxwell, a highly accredited journalist who explains medtech regulations in force and under development, has interviewed our  Executive Director: Gert Bos.‘The situation regarding the delay in the designation of notified bodies under the new EU medical devices regulations is looking so critical that some member state competent authorities have even started discussing whether they should step in and assess the conformity of some of the products themselves’ he said. The Industry has been hammering away the message that the medtech system is heading for crisis. A fallback plan is under review as authorities share industry’s concerns. Authorities are considering reviewing some products, among other solutions.For the whole interview, please go to: https://pages.pharmaintelligence.informa.com/MTI-article

Gert W. Bos, PhD, Fraps
Post date: June 06, 2019
Tags
How can we help you? Contact us